Suchbegriffe: ORGANOPLATINUM COMPOUNDS - THERAPEUTIC USE , . Treffer: 3
Hann, A; Nosalski, E; Hermann, PC; Egger, J; Seufferlein, T; Keller, F
Chemotherapeutic agents eligible for prior dosing in pancreatic cancer patients requiring hemodialysis: a systematic review
.
Clin Nephrol. 2018; 90(2):125-141
Doi: 10.5414/CN109327
Web of Science
PubMed
FullText
FullText_MUG
Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691
Doi: 10.21873/anticanres.11617
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gerger, A; El-Khoueiry, A; Zhang, W; Yang, D; Singh, H; Bohanes, P; Ning, Y; Winder, T; Labonte, MJ; Wilson, PM; Benhaim, L; Paez, D; El-Khoueiry, R; Absenger, G; Lenz, HJ
Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
Clin Cancer Res. 2011; 17(17):5783-5792
Doi: 10.1158/1078-0432.CCR-11-1115
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG